Health News

Health News

  • 16.03.2025 19:31
  • business-standard.com
  • Keywords: dangerous, dangerous

India's adult obesity rates have surged, with projections reaching 173.73 million by 2050. The weight-loss market is booming, growing from $25 billion in 2024 to an expected $55 billion by 2033. Generic drug availability has increased post-patent expirations, impacting global markets and safety monitoring efforts.

Coinbase NewsFerrari NewsRivian NewsSMCI News
open_in_newOriginal article

Estimated market influence

Mankind

Negativesentiment_dissatisfied
Analyst rating: N/A

Mankind is a company that has been mentioned in the text.

Alkem

Negativesentiment_dissatisfied
Analyst rating: N/A

Alkem is a company that has been mentioned in the text.

Context

Business Insights and Market Implications Analysis

Market Trends

  • Obesity Growth in India: The number of obese adults in India increased from 5.76 million in 1991 to 46.78 million in 2021, projected to reach 173.73 million by 2050.
  • Weight-Loss Market Expansion: The weight-loss market grew to $25 billion in 2024 and is expected to expand to $55 billion by 2033.
  • Generic Drug Competition: Pharmarack reported 226 vildagliptin brands available post-patent expiry (December 2019), indicating increased competition in the diabetes market.
  • Healthy Food Demand: Order volumes for healthy food staples and snacks surged by 60% year-on-year, reflecting changing consumer preferences.

Competitive Dynamics

  • Generic Drug Launches: Mankind, Alkem, and Glenmark launched generic versions of empagliflozin, intensifying competition in the diabetes market.
  • Adverse Event Reporting: India accounts for nearly 50% of generic drugs exported to the US, implying a proportional share of adverse event reporting.

Regulatory Considerations

  • Parliamentary Concerns: The parliamentary panel raised concerns over the scheme's absorption capacity and implementing agency efficiency, potentially impacting regulatory dynamics.
  • Stricter Enforcement: 1,504 errant hospitals were penalized Rs 122 crore, with 549 suspended, signaling stricter regulatory oversight in healthcare.

Long-term Effects

  • Global Talent Shift: Indian doctors finding better opportunities abroad may impact the local healthcare system's talent pool.
  • Personalized Medicine: The drug vepdegestrant showed limited success for all patients but met goals for a subset with specific genetic mutations, highlighting the growing importance of personalized medicine.

Strategic Considerations

  • Market Expansion Opportunities: The booming weight-loss market and surge in healthy food demand present opportunities for businesses in these sectors.
  • Regulatory Compliance: Stricter enforcement and concerns over scheme efficiency suggest that businesses must focus on compliance and operational improvements.